83_FR_35807 83 FR 35662 - Meeting of the President's Council on Sports, Fitness, and Nutrition

83 FR 35662 - Meeting of the President's Council on Sports, Fitness, and Nutrition

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 145 (July 27, 2018)

Page Range35662-35663
FR Document2018-16056

As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services (HHS) is hereby giving notice that the President's Council on Sports, Fitness, and Nutrition (PCSFN) will hold its annual meeting. The meeting will be open to the public.

Federal Register, Volume 83 Issue 145 (Friday, July 27, 2018) 
[Federal Register Volume 83, Number 145 (Friday, July 27, 2018)]
[Notices]
[Pages 35662-35663]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-16056]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the President's Council on Sports, Fitness, and 
Nutrition

AGENCY: President's Council on Sports, Fitness, and Nutrition, Office 
of the Assistant Secretary for Health, Office of the Secretary, 
Department of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services (HHS) is hereby giving notice 
that the President's Council on Sports, Fitness, and Nutrition (PCSFN) 
will hold its annual meeting. The meeting will be open to the public.

DATES: The meeting will be held on September 21, 2018, from 9:30 a.m. 
to 12:30 p.m.

ADDRESSES: Newseum, Knight Conference Center 7th Floor, 555 
Pennsylvania Ave. NW, Washington, DC 20001.

FOR FURTHER INFORMATION CONTACT: Ms. Holli M. Richmond, Executive 
Director, Office of the President's Council on Sports, Fitness, and 
Nutrition, Tower Building, 1101 Wootton Parkway, Suite 560, Rockville, 
MD 20852, (240) 276-9567. Information about PCSFN, including details 
about the upcoming meeting, can be obtained at www.fitness.gov.

SUPPLEMENTARY INFORMATION: The primary functions of the PCSFN include 
(1) advising the President, through the Secretary, concerning progress 
made in carrying out the provisions of Executive Order 13265, as 
amended by Executive Order 13824, and recommending to the President, 
through the Secretary, actions to accelerate such progress; (2) 
recommending to the Secretary a national strategy to expand children's 
participation in youth sports, encourage regular physical activity, 
including active play and promote good nutrition for all Americans. 
Recommendations may address, but are not necessarily limited to, 
increasing awareness of the benefits of participation in sports and 
regular physical activity, as well as the importance of good nutrition; 
promoting private and public sector strategies to increase 
participation in sports, encourage regular physical activity, and 
improve nutrition; developing metrics that gauge youth sports 
participation and physical activity to inform efforts that will improve 
participation in sports and regular physical activity among young 
Americans; and establishing a national and local strategy to recruit 
volunteers who will encourage and support youth participation in sports 
and regular physical activity, through coaching, mentoring, teaching, 
or administering athletic and nutritional programs. The Council's 
performance of these functions shall take into account the Department 
of Health and Human Services' Physical Activity Guidelines for 
Americans, including consideration for youth with disabilities.
    The Council shall meet, at a minimum, one time per fiscal year. The 
meeting will be held to (1) assess ongoing Council activities; and, (2) 
discuss and plan future projects and programs. The agenda for the 
planned meeting is being developed and will be posted at 
www.fitness.gov when it has been finalized.
    The meeting that is scheduled to be held on September 21, 2018, is 
open to the public and the media. Every effort will be made to provide 
reasonable accommodations for persons with disabilities and/or special 
needs who wish to attend the meeting. Persons with disabilities and/or 
special needs should call (240) 276-9567 no later than close of 
business Monday, September 10, 2018, to request accommodations. Members 
of the public who wish to attend the meeting are asked to pre-register 
by sending an email to

[[Page 35663]]

rsvp.fitness@hhs.gov or by calling (240) 276-9567. Registration for 
public attendance must be completed before close of business Wednesday, 
September 12, 2018.

    Dated: July 12, 2018.
Holli M. Richmond,
Executive Director, Office of the President's Council on Sports, 
Fitness, and Nutrition, U.S. Department of Health and Human Services.
[FR Doc. 2018-16056 Filed 7-26-18; 8:45 am]
BILLING CODE 4150-35-P

35662 Federal Register / Vol. 83, No. 145 / Friday, July 27, 2018 / Notices the party to whom FDA will send the from locations, and monitoring product 9567. Information about PCSFN, invoice for any fees that are assessed disposition. The direct hours spent on including details about the upcoming under this section. each such recall will be billed at the meeting, can be obtained at appropriate hourly rate shown in table www.fitness.gov. C. How much will this fee be? 2 of this document. SUPPLEMENTARY INFORMATION: The The fee is based on the number of direct hours spent on such V. How must the fees be paid? primary functions of the PCSFN include reinspections, including time spent (1) advising the President, through the An invoice will be sent to the Secretary, concerning progress made in conducting the physical surveillance responsible party for paying the fee after and/or compliance reinspection at the carrying out the provisions of Executive FDA completes the work on which the Order 13265, as amended by Executive facility, or whatever components of invoice is based. Payment must be made such an inspection are deemed Order 13824, and recommending to the within 90 days of the invoice date in President, through the Secretary, actions necessary, making preparations and U.S. currency by check, bank draft, or arrangements for the reinspection, to accelerate such progress; (2) U.S. postal money order payable to the recommending to the Secretary a traveling to and from the facility, order of the Food and Drug preparing any reports, analyzing any national strategy to expand children’s Administration. Detailed payment participation in youth sports, encourage samples or examining any labels if information will be included with the required, and performing other activities regular physical activity, including invoice when it is issued. active play and promote good nutrition as part of the OAI reinspection until the facility is again determined to be in VI. What are the consequences of not for all Americans. Recommendations compliance. The direct hours spent on paying these fees? may address, but are not necessarily each such reinspection will be billed at Under section 743(e)(2) of the FD&C limited to, increasing awareness of the the appropriate hourly rate shown in Act, any fee that is not paid within 30 benefits of participation in sports and table 2 of this document. days after it is due shall be treated as a regular physical activity, as well as the claim of the U.S. Government subject to importance of good nutrition; promoting IV. Fees for Non-Compliance With a private and public sector strategies to Recall Order Under Section 743(a)(1)(B) provisions of subchapter II of chapter 37 of title 31, United States Code. increase participation in sports, A. What will cause this fee to be encourage regular physical activity, and Dated: July 24, 2018. improve nutrition; developing metrics assessed? Leslie Kux, that gauge youth sports participation The fee will be assessed for not Associate Commissioner for Policy. and physical activity to inform efforts complying with a recall order under [FR Doc. 2018–16069 Filed 7–26–18; 8:45 am] that will improve participation in sports section 423(d) (21 U.S.C. 350l(d)) or BILLING CODE 4164–01–P and regular physical activity among section 412(f) of the FD&C Act (21 young Americans; and establishing a U.S.C. 350a(f)) to cover food recall national and local strategy to recruit activities associated with such order DEPARTMENT OF HEALTH AND volunteers who will encourage and performed by the Secretary (and by HUMAN SERVICES support youth participation in sports delegation, FDA) (section 743(a)(1)(B) of and regular physical activity, through the FD&C Act). Non-compliance may Meeting of the President’s Council on include the following: (1) Not initiating coaching, mentoring, teaching, or Sports, Fitness, and Nutrition administering athletic and nutritional a recall as ordered by FDA; (2) not conducting the recall in the manner AGENCY: President’s Council on Sports, programs. The Council’s performance of specified by FDA in the recall order; or Fitness, and Nutrition, Office of the these functions shall take into account (3) not providing FDA with requested Assistant Secretary for Health, Office of the Department of Health and Human information regarding the recall, as the Secretary, Department of Health and Services’ Physical Activity Guidelines ordered by FDA. Human Services. for Americans, including consideration for youth with disabilities. B. Who will be responsible for paying ACTION: Notice of meeting. The Council shall meet, at a this fee? SUMMARY: As stipulated by the Federal minimum, one time per fiscal year. The Section 743(a)(1)(B) of the FD&C Act Advisory Committee Act, the U.S. meeting will be held to (1) assess states that the fee is to be paid by the Department of Health and Human ongoing Council activities; and, (2) responsible party for a domestic facility Services (HHS) is hereby giving notice discuss and plan future projects and (as defined in section 415(b) of the that the President’s Council on Sports, programs. The agenda for the planned FD&C Act) and an importer who does Fitness, and Nutrition (PCSFN) will meeting is being developed and will be not comply with a recall order under hold its annual meeting. The meeting posted at www.fitness.gov when it has section 423 or under section 412(f) of will be open to the public. been finalized. the FD&C Act. In other words, the party The meeting that is scheduled to be DATES: The meeting will be held on paying the fee would be the party that held on September 21, 2018, is open to September 21, 2018, from 9:30 a.m. to the public and the media. Every effort received the recall order. 12:30 p.m. will be made to provide reasonable C. How much will this fee be? ADDRESSES: Newseum, Knight accommodations for persons with The fee is based on the number of Conference Center 7th Floor, 555 disabilities and/or special needs who direct hours spent on taking action in Pennsylvania Ave. NW, Washington, DC wish to attend the meeting. Persons amozie on DSK3GDR082PROD with NOTICES1 response to the firm’s failure to comply 20001. with disabilities and/or special needs with a recall order. Types of activities FOR FURTHER INFORMATION CONTACT: Ms. should call (240) 276–9567 no later than could include conducting recall audit Holli M. Richmond, Executive Director, close of business Monday, September checks, reviewing periodic status Office of the President’s Council on 10, 2018, to request accommodations. reports, analyzing the status reports and Sports, Fitness, and Nutrition, Tower Members of the public who wish to the results of the audit checks, Building, 1101 Wootton Parkway, Suite attend the meeting are asked to pre- conducting inspections, traveling to and 560, Rockville, MD 20852, (240) 276– register by sending an email to VerDate Sep<11>2014 17:38 Jul 26, 2018 Jkt 244001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\27JYN1.SGM 27JYN1

Federal Register / Vol. 83, No. 145 / Friday, July 27, 2018 / Notices 35663 rsvp.fitness@hhs.gov or by calling (240) The patent rights in these inventions Dated: July 20, 2018. 276–9567. Registration for public have been assigned to the Government Michael A. Shmilovich, attendance must be completed before of the United States of America. The Senior Licensing and Patenting Manager, close of business Wednesday, prospective patent license will be National Heart, Lung, and Blood Institute, September 12, 2018. granted worldwide and in a field of use Office of Technology Transfer and not broader than radiotherapeutics for Development. Dated: July 12, 2018. Holli M. Richmond, somatostatin-receptor expressing [FR Doc. 2018–16065 Filed 7–26–18; 8:45 am] Executive Director, Office of the President’s neuroendocrine tumors. BILLING CODE 4140–01–P Council on Sports, Fitness, and Nutrition, The invention pertains to a U.S. Department of Health and Human radiotherapeutic against neuroendocrine Services. DEPARTMENT OF HEALTH AND tumors that express somatostatin HUMAN SERVICES [FR Doc. 2018–16056 Filed 7–26–18; 8:45 am] receptor. Radionuclide therapies BILLING CODE 4150–35–P directed against tumors that express National Institutes of Health somatostatin receptors (SSTRs) have proven effective for the treatment of National Cancer Institute; Notice of DEPARTMENT OF HEALTH AND advanced, low- to intermediate-grade Closed Meetings HUMAN SERVICES neuroendocrine tumors. The subject Pursuant to section 10(d) of the radiotherapeutic covered by the subject National Institutes of Health Federal Advisory Committee Act, as patent estate includes a somatostatin amended, notice is hereby given of the Prospective Grant of Exclusive Patent (SST) peptide derivative like octreotate following meetings. License: Radiotherapeutics Against (TATE), conjugated to an Evans Blue The meetings will be closed to the Somatostatin-Receptor Expressing (EB) analog, and further chelated via public in accordance with the Neuroendocrine Tumors DOTA to therapeutic radionuclide 177Lu, a beta emitter. The EB analog provisions set forth in sections AGENCY: National Institutes of Health, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., reversibly binds to circulating serum as amended. The grant applications and HHS. albumin and improves the the discussions could disclose ACTION: Notice. pharmacokinetics of SST peptide confidential trade secrets or commercial derivatives and reduce peptide-receptor property such as patentable material, SUMMARY: The National Heart, Lung and radionuclide therapy toxicity. EB analog and personal information concerning Blood Institute (NHLBI), National conjugated to octreotate (EB- individuals associated with grant Institutes of Health, Department of DOTATATE) has been shown by the applications, the disclosure of which Health and Human Services, is inventors to provide reversible albumin would constitute a clearly unwarranted contemplating the grant of an exclusive binding in vivo and extended half-life in invasion of personal privacy. patent license to Molecular Targeting circulation. When EB-TATE is slowly Technologies, Inc. (MTTI); a Delaware Name of Committee: National Cancer released into the tumor corporation, with its principle place of Institute Special Emphasis Panel; U01 SEP: microenvironment, tumor uptake and business in West Chester, Pennsylvania, Glycobiologists Alliance for Cancer Research. internalization into SSTR positive Date: August 30, 2018. to practice the inventions embodied in the patent application listed in the tumors resulted in delivery of Time: 10:00 a.m. to 5:00 p.m. SUPPLEMENTARY INFORMATION section of radioactive particles and tumor cell Agenda: To review and evaluate grant this notice. killing. EB-TATE displayed significantly applications. more favorable pharmacokinetics than Place: National Cancer Institute, Shady DATES: Only written comments and/or Grove, 9609 Medical Center Drive, Room TATE alone by achieving higher tumor applications for a license which are 7W102, Rockville, MD 20850 (Telephone to non-tumor penetration as evidenced received by the NHLBI Office of Conference Call). by positron emission tomography. Contact Person: Shakeel Ahmad, Ph.D., Technology Transfer and Development August 27, 2018 will be considered. This notice is made in accordance Scientific Review Officer, Research with 35 U.S.C. 209 and 37 CFR part 404. Technology and Contract Review Branch, ADDRESSES: Requests for copies of the The prospective exclusive patent license Division of Extramural Activities, National patent applications, inquiries, and Cancer Institute, NIH, 9609 Medical Center comments relating to the contemplated will be royalty bearing and may be Drive, Room 7W102, Bethesda, MD 20892– exclusive patent license should be granted unless within fifteen (15) days 9750, 240–276–6349, ahmads@mail.nih.gov. directed to: Michael Shmilovich, Esq., from the date of this published notice, Name of Committee: National Cancer Senior Licensing and Patent Manager, the NHLBI receives written evidence Institute Special Emphasis Panel; NCI 31 Center Drive, Room 4A29, MSC2479, and argument that establishes that the Program Project IV (P01). Bethesda, MD 20892–2479, phone grant of the license would not be Date: September 27–28, 2018. number 301–435–5019, or shmilovm@ consistent with the requirements of 35 Time: 4:00 p.m. to 5:00 p.m. mail.nih.gov. U.S.C. 209 and 37 CFR part 404. Agenda: To review and evaluate grant applications. SUPPLEMENTARY INFORMATION: The Complete applications for a license in Place: Bethesda North Marriott Hotel & following and all continuing U.S. and the prospective field of use that are Conference Center, 5701 Marinelli Road, foreign patents/patent applications timely filed in response to this notice North Bethesda, MD 20852. thereof are the intellectual properties to will be treated as objections to the grant Contact Person: Sanita Bharti, Ph.D., be licensed under the prospective of the contemplated exclusive patent Scientific Review Officer, Research Program amozie on DSK3GDR082PROD with NOTICES1 license. Review Branch, Division of Extramural agreement to MTTI: HHS Ref. E–150– Activities, National Cancer Institute, NIH, 2016–1–PCT–01, International Patent Comments and objections submitted 9609 Medical Center Drive, Room 7W122, Application PCT/US2017/054863 filed to this notice will not be made available Bethesda, MD 20892–9750, 240–276–5909, October 3, 2017, entitled ‘‘Chemical for public inspection and, to the extent sanitab@mail.nih.gov. Conjugates of Evans Blue Derivatives permitted by law, will not be released (Catalogue of Federal Domestic Assistance and Their Use As Radiotherapy And under the Freedom of Information Act, Program Nos. 93.392, Cancer Construction; Imaging Agents.’’ 5 U.S.C. 552. 93.393, Cancer Cause and Prevention VerDate Sep<11>2014 17:38 Jul 26, 2018 Jkt 244001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\27JYN1.SGM 27JYN1


Document Created: 2018-07-27 04:06:09
Document Modified: 2018-07-27 04:06:09
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting.
DatesThe meeting will be held on September 21, 2018, from 9:30 a.m. to 12:30 p.m.
ContactMs. Holli M. Richmond, Executive Director, Office of the President's Council on Sports, Fitness, and Nutrition, Tower Building, 1101 Wootton Parkway, Suite 560, Rockville, MD 20852, (240) 276-9567. Information about PCSFN, including details about the upcoming meeting, can be obtained at www.fitness.gov.
FR Citation83 FR 35662 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR